Advertisement

Topics

Auxilium Company Profile

10:53 EDT 26th September 2017 | BioPortfolio

Auxilium means "assistance" in Latin, and that's a fitting description for all of our pharmaceutical research, development and marketing efforts. Auxilium is focused on assisting people as they age by providing pharmaceutical products that promote better health and functionality.

Location

40 Valley Stream Parkway
Malvern
Pennsylvania
19355
United States of America

Contact

Phone: 484-321-5900
Fax: 484-321-5999
Email: hrdept@auxilium.com


News Articles [16 Associated News Articles listed on BioPortfolio]

Financial Survey: Auxilium Pharmaceuticals

Auxilium Pharmaceuticals and Alimera Sciences are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institut...

Auxilium Pharmaceuticals to Announce Fourth Quarter 2011 Results and Conduct Conference Call on Thursday, February 23, 2012

MALVERN, Pa., Feb. 9, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the fourth quarter 2011 on Thursday, Febr...

Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference

MALVERN, Pa., Feb. 1, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the Leerink Swann 2012 Global Healthcare...

BioSpecifics Technologies Corp. to Present at the 8th Annual JMP Securities Healthcare Conference

LYNBROOK, N.Y., July 2, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX&#...

Auxilium Pharmaceuticals to Present at the J.P. Morgan 2013 Healthcare Conference

MALVERN, Pa., Jan. 3, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the J.P. Morgan 2013 Healthcare Conference t...

Auxilium Pharmaceuticals, Inc. to Present at the 8th Annual JMP Securities Healthcare Conference

CHESTERBROOK, Pa., July 3, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the 8th Annual JMP Securities Healthca...

Auxilium Pharmaceuticals, Inc. Announces Expansion of Its Exclusive License for XIAFLEX® (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication

MALVERN, Pa., Jan. 7, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium"), a specialty biopharmaceutical company, today announced that it has exercised its exc...

Auxilium Pharmaceuticals, Inc. and Xstelos Holdings, Inc. Receive 505(b)(2) Paragraph IV Certification Notice from Upsher-Smith Laboratories, Inc. for Testim®

MALVERN, Pa. and NEW YORK, Jan. 3, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and Xstelos Holdings, Inc. (OTCQB: XTLS) ("Xstelos") today announced that t...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Xiaflex [Auxilium]

These highlights do not include all the information needed to use XIAFLEX safely and effectively. See full prescribing information for XIAFLEX. XIAFLEX (collagenase clostridium histolyticum) for injec...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease

This a Phase 4 non-treatment, long-term follow-up study of subjects who received AA4500 in a 12-month double blind placebo-controlled study (AUX CC 803 or AUX-CC-804) or in a 9-month open ...

Companies [5 Associated Companies listed on BioPortfolio]

Auxilium

Auxilium means "assistance" in Latin, and that's a fitting description for all of our pharmaceutical research, development and marketing efforts. Auxilium is focused on assisting people as they age by...

Auxilium Pharmaceuticals

Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While we remain dedicated to this founding principle,...

Auxilium Pharmaceuticals, Inc.

Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While we remain dedicated to this founding principl...

CPEX Pharmaceuticals, Inc.

CPEX Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, licensing and commercialization of pharmaceutical products utilizing CPEXâ...

CPEX Pharmaceuticals Inc.

CPEX Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, licensing and commercialization of pharmaceutical products utilizing CPEXâ...

More Information about "Auxilium" on BioPortfolio

We have published hundreds of Auxilium news stories on BioPortfolio along with dozens of Auxilium Clinical Trials and PubMed Articles about Auxilium for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Auxilium Companies in our database. You can also find out about relevant Auxilium Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record